Method and kit for diagnosing liver cancer by use of the ratio of change in serum miRNA quantity
A kit and liver cancer technology, applied in the fields of immunology and molecular biology, can solve problems such as diagnostic errors, instability, and poor repeatability, and achieve the effect of improving accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] The fundamental purpose of the present invention is to diagnose liver cancer by measuring the ratio of two or more groups of miRNAs, so as to improve the accuracy of liver cancer diagnosis. And measure the amount of every group of miRNA then can adopt different methods, the embodiment one of the method for measuring miRNA amount of the present invention is as follows:
[0058] Step 1: Blood samples were collected from the hospital in advance and divided into a healthy group and a confirmed liver cancer group. Divide each group into two groups, which are healthy group: A1, A2, and liver cancer group: B1, B2. The following steps 2, 3, and 4 are used to measure the amount of miRNA in each group of samples.
[0059] Step 2: Take 2ml of peripheral blood from each group of samples, place it at room temperature for 1 hour, and centrifuge at 1000g for 10 minutes. Then, the blood was drawn and transferred to a 1.5ml tube and centrifuged at 16000g for 20 minutes to remov...
comparative approach 1
[0100] Comparison scheme 1 of the present invention: direct comparison of two sets of data on the decrease degree of Mir-122a serum. Such as figure 1 As shown, the amount of Mir-122a in the test group 1 is between 0 and 1, and the amount of Mir-122a in the test group 2 is between 2 and 4. Well diagnosed liver cancer.
comparative approach 2
[0101] Comparison scheme 2 of the present invention: direct comparison of two sets of data on the degree of increase in Mir-222 serum. Such as figure 2 As shown, the amount of Mir-222 in the test group 1 is between 0.8 and 2, and the amount of Mir-222 in the test group 2 is between 4 and 8. The data of the two groups are also very different, so only one Mir-222 value Can not be a good diagnosis of liver cancer.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com